This survey has been developed by Monash University and reviewed by the ELF COPD Patient Advisory Group (PAG). The aim of the survey is to help researchers design strategies to ensure people living with COPD can receive the right dose of corticosteroid tablets at the right time.

Who can take part in the survey?

Any person diagnosed with COPD can take part in the survey.

What is the purpose of the survey?

Corticosteroid tablets are a recommended treatment for flare-ups of COPD but they may also have serious side effects. These could include an increased risk of bone fractures, diabetes and heart conditions, especially when taken frequently and at high doses.

It is important that people with COPD are given a safe dose of corticosteroid tablets and know when to take them.

If you want to learn more about the survey, please click on the links to be taken to the survey. If you choose to take part, the survey should take no longer than 10 minutes to complete.

This survey is anonymous and you can leave the survey at any time.

Please note the deadline for responses is 30 March 2025.